Home › Macular Degeneration › South Carolina
Macular Degeneration clinical trials in South Carolina
8 studies for Macular Degeneration are looking for participants at sites in South Carolina.
Cities in South Carolina
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Charleston Neuroscience Institute, LLC, Beaufort
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Consultants of Carolina, Greenville
- Charleston Neuroscience Institute LLC, Ladson
- Charleston Neuroscience Institute, LLC, Mt. Pleasant
- and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Palmetto Retina Center, Aiken
- Charleston Neuroscience Institute - Bluffton (Site 124), Bluffton
- Charleston Neuroscience Institute (Site 104), Charleston
- and 1 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Sep 18, 2026 · NCT07440225Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Charleston Neuroscience Institute, Mt. Pleasant
- Palmetto Retina Center, West Columbia
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Palmetto Retina Center, LLC, West Columbia
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Charleston Neuroscience Institute (Site 034), Beaufort
- Palmetto Retina Center, Florence
- Charleston Neuroscience Institute, Ladson
- and 1 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 122, West Columbia
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Charleston Neuroscience Institute, LLC, Bluffton
- Carolina Eyecare, Mt. Pleasant
- Palmetto Retina Center, West Columbia
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.